technetium tc 99m hydroxymethylene diphosphonate has been researched along with Disease Exacerbation in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Büll, U; Cremerius, U; Jakse, G; Ostwald, E; Sabri, O | 1 |
1 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Disease Exacerbation
| Article | Year |
|---|---|
[Bone scintigraphy and rhenium radioisotope management in the course of metastatic prostatic cancer].
Topics: Aged; Androgen Antagonists; Bone Neoplasms; Disease Progression; Follow-Up Studies; Humans; Male; Pain; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate | 1999 |